ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 740613 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 740613; 2) Community: the network communities that were significantly associated with the response to NSC 740613; 3) Molecule: the relationships between components within communities and NSC 740613; 4) MDR: the compounds that were significantly associated with the NSC 740613.

NSC Compound Enrichment Correlation
NSC 639174 Camptothecin Derivative 0.00845932736945082 0.2458038
NSC 639186 Raltitrexed 0.00845932736945082 -0.026947616
NSC 659950 7-O-(3,4-Di-O-acetyl-2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.00845932736945082 0.24952724
NSC 681635 Camptothecin Derivative 0.00845932736945082 0.17758002
NSC 685005 Null 0.00845932736945082 -0.10438099
NSC 692641 Null 0.00845932736945082 -0.0030751649
NSC 697167 Null 0.00845932736945082 0.055394426
NSC 708446 Null 0.00845932736945082 0.082165698
NSC 732800 methyl 4-[3-chloro-4-(3-chloro-2-methylanilino)-2,5-dioxo-2,5-dihyd ro-1H-1-pyrrolylmethyl]benzoate 0.00845932736945082 -0.12185117
NSC 1433 4-(BUTYLAMINO)-1-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE 0.0112425217758227 0.064980598
Total:102  Current:27    [First] [Prev] [Next] [Last]